352 related articles for article (PubMed ID: 10554038)
21. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase.
Chambers SK; Wang Y; Gertz RE; Kacinski BM
Cancer Res; 1995 Apr; 55(7):1578-85. PubMed ID: 7882368
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
[TBL] [Abstract][Full Text] [Related]
23. All-trans retinoic acid induces monocyte growth factor receptor (c-fms) gene expression in HL-60 leukemia cells.
Hsu HC; Yang K; Kharbanda S; Clinton S; Datta R; Stone RM
Leukemia; 1993 Mar; 7(3):458-62. PubMed ID: 8445950
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of the c-fms proto-oncogene autocrine loop and tumor phenotype in glucocorticoid stimulated human breast carcinoma cells.
Toy EP; Lamb T; Azodi M; Roy WJ; Woo HH; Chambers SK
Breast Cancer Res Treat; 2011 Sep; 129(2):411-9. PubMed ID: 21063905
[TBL] [Abstract][Full Text] [Related]
25. Colony stimulating factor-1 induced growth stimulation of v-fms transformed fibroblasts.
Lyman SD; Park L; Rohrschneider LR
Oncogene; 1988 Oct; 3(4):391-5. PubMed ID: 2856249
[TBL] [Abstract][Full Text] [Related]
26. Macrophage colony-stimulating factor (CSF-1) enhances invasiveness in CSF-1 receptor-positive carcinoma cell lines.
Filderman AE; Bruckner A; Kacinski BM; Deng N; Remold HG
Cancer Res; 1992 Jul; 52(13):3661-6. PubMed ID: 1535551
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR
Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327
[TBL] [Abstract][Full Text] [Related]
28. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
29. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T
Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847
[TBL] [Abstract][Full Text] [Related]
30. FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance.
Taylor JR; Brownlow N; Domin J; Dibb NJ
Oncogene; 2006 Jan; 25(1):147-51. PubMed ID: 16170366
[TBL] [Abstract][Full Text] [Related]
31. Transformation of murine fibroblasts by a retrovirus encoding the murine c-fms proto-oncogene.
Rohrschneider LR; Rothwell VM; Nicola NA
Oncogene; 1989 Aug; 4(8):1015-22. PubMed ID: 2548144
[TBL] [Abstract][Full Text] [Related]
32. Induction of sustained expression of proto-oncogene c-fms by platelet-derived growth factor, epidermal growth factor, and basic fibroblast growth factor, and its suppression by interferon-gamma and macrophage colony-stimulating factor in human aortic medial smooth muscle cells.
Inaba T; Gotoda T; Harada K; Shimada M; Ohsuga J; Ishibashi S; Yazaki Y; Yamada N
J Clin Invest; 1995 Mar; 95(3):1133-9. PubMed ID: 7883962
[TBL] [Abstract][Full Text] [Related]
33. Expression of the macrophage growth factor, CSF-1 and its receptor c-fms by a Hodgkin's disease-derived cell line and its variants.
Paietta E; Racevskis J; Stanley ER; Andreeff M; Papenhausen P; Wiernik PH
Cancer Res; 1990 Apr; 50(7):2049-55. PubMed ID: 2156611
[TBL] [Abstract][Full Text] [Related]
34. CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract.
Kacinski BM
Mol Reprod Dev; 1997 Jan; 46(1):71-4. PubMed ID: 8981366
[TBL] [Abstract][Full Text] [Related]
35. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).
Roussel MF; Dull TJ; Rettenmier CW; Ralph P; Ullrich A; Sherr CJ
Nature; 1987 Feb 5-11; 325(6104):549-52. PubMed ID: 3027579
[TBL] [Abstract][Full Text] [Related]
36. Expression of M-CSF and its receptor (C-FMS) during factor-independent cell line evolution from hematopoietic progenitor cells cocultivated with gamma irradiated marrow stromal cell lines.
Greenberger JS; Sakakeeny MA; Leif J; Anklesaria P; Pierce JH; Shadduck RK
Leukemia; 1992 Jul; 6(7):626-33. PubMed ID: 1385639
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the c-fms promoter in murine tumour cell lines.
Favot P; Yue X; Hume DA
Oncogene; 1995 Oct; 11(7):1371-81. PubMed ID: 7478559
[TBL] [Abstract][Full Text] [Related]
38. Granulocyte macrophage colony-stimulating factor enhances retinoic acid-induced gene expression.
Shimizu T; Esaki L; Mizuno H; Takeda K
J Leukoc Biol; 2006 Oct; 80(4):889-96. PubMed ID: 16885501
[TBL] [Abstract][Full Text] [Related]
39. Induction of VEGF gene expression by retinoic acid through Sp1-binding sites in retinoblastoma Y79 cells.
Akiyama H; Tanaka T; Maeno T; Kanai H; Kimura Y; Kishi S; Kurabayashi M
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1367-74. PubMed ID: 11980848
[TBL] [Abstract][Full Text] [Related]
40. Repression of the CSF-1 receptor (c-fms proto-oncogene product) by antisense transfection induces G1-growth arrest in L6 alpha 1 rat myoblasts.
Borycki AG; Foucrier J; Saffar L; Leibovitch SA
Oncogene; 1995 May; 10(9):1799-811. PubMed ID: 7753556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
